The advancement in recombinant technology has led to the emergence of DNA & recombinant vaccines. These vaccines are effective over traditionally developed vaccines in preventing infections.

Portland, OR -- (SBWire) -- 02/26/2018 --Animal Vaccines Market report, published by Allied Market Research, forecasts that the global market is expected to garner $9,159 million by 2022, registering a CAGR of 5.2% during the period.

Get PDF Brochure For Details: https://www.alliedmarketresearch.com/request-sample/1988

The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the industry is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, it is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is sub-segmented into dogs, cats, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Animal vaccines are essential to ensure better animal health and welfare. Various vaccines such as attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines aid to provide protection against multiple diseases, including rabies and foot & mouth disease. These vaccines offer cost-effective solutions to treat such diseases instead of excessive antibiotic administration.

Connect to analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1988

The animal vaccines market is growing at a steady pace owing to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, rise in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the market growth. For instance, Elanco invested two-thirds of the budget for food animal unit to develop vaccines and reduce the use of antibiotics, in August 2016. Moreover, rise in demand for animal vaccines led to the emergence of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva that prevents against infectious bronchitis virus (IBV), in February 2017.

Increase in adoption of companion animals in the developing countries is the major factor that drives the growth of this market. The market has witnessed moderate growth in recent years due to emerging diseases that affect livestock. The outbreak of epidemics results in severe mass wipeouts of animals, and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases that affect animals pose a threat to the public health, hence avoiding transmission of such diseases via vaccination is a significant factor in disease management.

Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/1988

Animal Vaccines Market Key Segments:

By Product
Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines

By Animal Type
Companion Animals
Dogs
Cats
Others
Cattle
Pigs
Poultry
Sheep